Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Studies on human blood platelets

Tools
- Tools
+ Tools

Stott, Andrew James (1990) Studies on human blood platelets. PhD thesis, University of Warwick.

[img]
Preview
Text
WRAP_thesis_Stott_1990.pdf - Submitted Version

Download (12Mb) | Preview
Official URL: http://webcat.warwick.ac.uk/record=b1410301~S1

Request Changes to record.

Abstract

This
project was undertaken to increase the understanding of platelet function, with
paticular emphasis on abnormal platelets in diabetes mellitus, and improving the quality of
platelet concentrates for transfusion.
{1} Potential
platelet antagonists,
including PGE1,
verapamil,
insulin
and
hirudin,
were added to platelet concentrates
in
an attempt to
improve
the recovery and shelf-life of the
concentrate.
Each "preservative"
caused some
improvement in
platelet concentrate quality, as
measured
by functional
tests, and radio-immunoassay
for the platelet activation marker,
B-
thromboglobulin. The best
results were obtained with the addition of
PGE1,
which
facilitated
recovery of all samples to which
it
was added, suggesting a cheap way of ensuring
consistently good platelet concentrates.
{2} Various investigations
were carried out regarding abnormal platelet
function in
diabetes mellitus.
No
significant
differences
were
found in
the responses of platelets
from
diabetics
and age-matched controls to the calcium-channel
blocking drug, Verapamil, in
vitro.
Similarly, the
capacity of
diabetic
platelets to produce malondialdehyde, a
by-product
of thromboxane
A2
synthesis, was not significantly
different from
control platelets.
The
use of insulin
in
aggregometry studies showed, surprisingly, that
insulin
could
have
a pro-aggregatory effect on platelets
from diabetics, but
not
those
from healthy
controls.
In
addition, evidence
for the existence of a platelet aggregation-enhancing
factor in
the
plasma of
diabetics
and older controls was obtained.
{3} Extensive
tests to
investigate
the nature of spontaneous platelet aggregation
(SPA) in
whole
blood have
established the existence of two types of
SPA, (i) ADP-dependent, and
(ii)
ADP-independent. The
results obtained suggest a major role
for
erythrocytes in the
development
of
inappropriate
platelet aggregation.

Item Type: Thesis or Dissertation (PhD)
Subjects: Q Science > QD Chemistry
R Medicine > R Medicine (General)
Library of Congress Subject Headings (LCSH): Blood platelets, Diabetes -- Research
Official Date: September 1990
Dates:
DateEvent
September 1990Submitted
Institution: University of Warwick
Theses Department: Department of Chemistry
Thesis Type: PhD
Publication Status: Unpublished
Supervisor(s)/Advisor: Swoboda, B. E. P.
Sponsors: City of Coventry's Charities Commission ; University of Warwick
Extent: 212 leaves : illustrations
Language: eng

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us